To make clinical trials equitable, cancer groups evaluate restrictive eligibility criteria – The Cancer Letter
Emergent public-private partnerships (PPPs) have risen to the occasion to streamline and coordinate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. With these monumental efforts have come important public discussions about equitable access and representation in clinical trials (CTs). Equitable access to CTs—that is, the opportunity for all patients to access CTs that may…
